ICRA reaffirms ratings of TTK Healthcare’s bank facilities

12 May 2017 Evaluate

Credit rating agency, ICRA has re-affirmed the long-term rating of ‘A+’ outstanding on the Rs 22.50 crore fund-based bank facilities of TTK Healthcare. The rating agency has also reaffirmed the short-term rating of ‘A1+’ outstanding on the Rs 6 crore fund-based facilities (sub limits), the Rs 4.75 crore non-fund based facilities and the Rs 0.25 crore proposed facilities of the company. The outlook on the long-term rating is stable.

TTK Healthcare commenced operations as a pharmaceutical company. Over the years, it diversified its presence across industries and its revenue sources were distributed across many product categories including contraceptives, gripe water, cosmetics, medical devices, home-care products, and food products.

TTK Healthcare Share Price

1163.25 -15.85 (-1.34%)
09-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.10
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...